Who invested in Gemini Therapeutics?
Gemini Therapeutics's investors include Atlas Venture, OrbiMed, Fidelity, Wellington Management and Foresite Capital, and 1 more on record.
United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$138Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
From the SEC filings it signed: 1 on the team.
On the board, as filediCarl GordonJason RhodesJean George
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Gemini Therapeutics's investors include Atlas Venture, OrbiMed, Fidelity, Wellington Management and Foresite Capital, and 1 more on record.
Gemini Therapeutics has raised $138M across 2 rounds since 2017.
Gemini Therapeutics's most recent round was an Undisclosed round of $95M in Feb 2021.
Its most recent round, $95M in Feb 2021, is also its largest on record.
Gemini Therapeutics's first round on record, in Oct 2017, was backed by Atlas Venture, OrbiMed and Lightstone Ventures.
Gemini Therapeutics's latest named round is an Undisclosed round, in Feb 2021.
Gemini Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.